Results 131 to 140 of about 9,107,460 (340)

Why do we need quality measures in emergency medicine?

Journal of the American College of Emergency Physicians Open
Quality measures increasingly influence the delivery and reimbursement of care provided in emergency departments. While emergency physicians are accustomed to using quality measures to improve care delivery, payors, including the Centers for Medicare and
Shamie Das, Gregg Miller, Christopher Libby, Cameron J. Gettel, Elaine Rabin, Michelle Lin   +5 more
doaj   +1 more source

How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU

British Journal of Clinical Pharmacology, EarlyView.
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley   +1 more source

Patterns in the influence of funding and reimbursement on the development and implementation of healthcare innovation: A systematic review

Journal of Open Innovation: Technology, Market and Complexity
Innovation is considered essential to the quality and sustainability of healthcare systems. However, the path from innovative idea to adopted reality is complex and fraught with barriers.
Sanne Allers, Frank Eijkenaar, Erik M. van Raaij, Frederik T. Schut   +3 more
doaj   +1 more source

Beyond the label: Rethinking off‐label drug use in paediatrics. Towards a scientifically grounded and safer future for paediatric pharmacotherapy

British Journal of Clinical Pharmacology, EarlyView.
Abstract Despite regulatory progress being made in the past two decades, off‐label drug use in paediatrics remains pervasive, with prevalence estimated between 3% and 97% of prescriptions across different clinical settings. Off‐label use—defined as prescribing outside the conditions described in the Summary of Product Characteristics (SmPC)—is often ...
Tjitske M. van der Zanden, Miriam G. Mooij, Matthijs de Hoog, Saskia N. de Wildt   +3 more
wiley   +1 more source

Efficacy, safety and cost‐effectiveness of CAR‐T therapy

British Journal of Clinical Pharmacology, EarlyView.
CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher, Amina Džidić‐Krivić, Emma Pinjic, Nejra Selak, Kanita Omerbasic, Alexandar Chupin, Andrej Belancic, Almir Fajkic   +7 more
wiley   +1 more source

Do drugs approved via expedited approval pathways have therapeutic advantages? A systematic review and meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Regulators use expedited approval pathways to speed market approval and patient access to promising new drugs. However, there is uncertainty about whether these pathways are successful in approving drugs with significant therapeutic advantages. This systematic review aims to examine the safety, effectiveness and cost‐effectiveness of drugs approved via
Ashleigh Hooimeyer, Eliza J. McEwin, Zhicheng Wang, Joel Lexchin, Barbara Mintzes   +4 more
wiley   +1 more source

Access to Medicines in Bulgaria and North Macedonia: Legislative, Pricing, and Reimbursement Perspectives

Pharmacy
National legislative frameworks governing prescribing, pricing, reimbursement, and dispensing play a decisive role in shaping access to medicines. This study examines the financial availability of medicines in Bulgaria and North Macedonia through a ...
Anna Todorova, Dijana Miceva, Mariya Ivanova, Tanya Kazakova, Bistra Angelovska   +4 more
doaj   +1 more source

Human Service Nonprofits and Government Collaboration: Findings from the 2010 National Survey of Nonprofit Government Contracting and Grants [PDF]

, 2010
Presents nonprofit survey results on government contracts; their share of revenue; problems, including late or partial payments, complex application and reporting processes, and changes to contract terms; how nonprofits cope with them; and the ...
Elizabeth T. Boris, Erwin de Leon, Katie L. Roeger, Milena Nikolova   +3 more
core  

Acceptability to general practitioners of national health insurance and capitation as a reimbursement mechanism.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1996
To determine general practitioners' attitudes to national health insurance (NHI) and to capitation as a mechanism of reimbursement. To explore determinants of these attitudes.Cross-sectional survey by means of telephone interviews; four focus group discussions.Cape Peninsula.174 GPs randomly sampled from a total population of 874.Acceptance of NHI ...
Blecher, M.S., Bachmann, M.O., McIntyre, D.   +2 more
openaire   +2 more sources

Digital diagnostics, biomarkers and therapeutics in an evolving healthcare system: From promise to practice

British Journal of Clinical Pharmacology, EarlyView.
Abstract Health care is shifting towards a digital‐guided system, integrating digital diagnostics, biomarkers and therapeutics in many care pathways. However, despite rapid technological advancement and preliminary adoption accelerated by the COVID‐19 pandemic, a significant implementation gap persists. This narrative review explores the causes of this
Mees H. P. Stoop, Gertjan J. A. Driessen, Adam F. Cohen, Matthijs D. Kruizinga   +3 more
wiley   +1 more source